SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Detroit Prepares to Issue Another 50 Cannabis Licences

    By

    Detroit is gearing up to launch the second phase of its adult-use cannabis licence roll out, with dozens more businesses due to open soon.

    Yesterday (June 28), the city’s council waved through a resolution to begin accepting applications for recreational operators, Detroit Metro Times reported.

    To-date, Detroit has issued 36 adult-use licences, at least 20 of which were social equity applicants.

    Now, the city is gearing up to accept applications for another 50 licences, including 30 adult-use dispensaries, 10 microbusinesses and 10 consumption establishments.

    READ MORE: New York Cannabis Industry Workforce Development Initiative Established to Target Justice-Impacted Communities

    Of these, half will be granted to social equity applicants, who must live in a community disproportionately impacted by the war on drugs or have been convicted of a cannabis-related offence.

    Adult-use cannabis sales were legalised in Michigan in 2019, but Detroit has postponed issuing licences until it was able to create a framework making it easier for locals to break into the burgeoning industry.

    Eventually, Detroit plans to award licences for up to 100 dispensaries, 30 micro businesses and 30 consumption lounges, with half of the total going to social equity enterprises.

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free